Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04752215
Title A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Having the B7-H6 Marker
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Valkyrie Clinical Trials Recruiting Los Angeles California 90067 United States Details
HealthONE Recruiting Denver Colorado 80218 United States Details
Florida Cancer Specialists Recruiting Sarasota Florida 34232 United States Details
Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology, PLLC Recruiting Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Center Recruiting Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from for the field